|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-7-27
|
|
pubmed:abstractText |
Triple therapy including a proton pump inhibitor, clarithromycin, and amoxicillin (PPI-CA) is the first-choice treatment used for H. pylori eradication. The efficacy of this treatment is declining of late, and alternative therapies are currently under evaluation.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1130-0108
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
101
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
395-8, 399-402
|
|
pubmed:meshHeading |
pubmed-meshheading:19630462-Adolescent,
pubmed-meshheading:19630462-Adult,
pubmed-meshheading:19630462-Aged,
pubmed-meshheading:19630462-Aged, 80 and over,
pubmed-meshheading:19630462-Amoxicillin,
pubmed-meshheading:19630462-Anti-Bacterial Agents,
pubmed-meshheading:19630462-Drug Therapy, Combination,
pubmed-meshheading:19630462-Female,
pubmed-meshheading:19630462-Humans,
pubmed-meshheading:19630462-Male,
pubmed-meshheading:19630462-Middle Aged,
pubmed-meshheading:19630462-Ofloxacin,
pubmed-meshheading:19630462-Prospective Studies,
pubmed-meshheading:19630462-Proton Pump Inhibitors,
pubmed-meshheading:19630462-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Efficacy of triple therapy with a proton pump inhibitor, levofloxacin, and amoxicillin as first-line treatment to eradicate Helicobacter pylori.
|
|
pubmed:affiliation |
Unit for the Clinical Management of Digestive Diseases, Hospital Universitario de Valme, Sevilla, Spain. mcastrof@meditex.es
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
